Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Yoga for Cancer-Related Fatigue in Survivors of Hematopoietic Cell Transplantation: A Feasibility Study.

Baydoun M, Barton DL, Peterson M, Wallner LP, Visovatti MA, Arslanian-Engoren C, Choi SW.

J Pain Symptom Manage. 2019 Nov 23. pii: S0885-3924(19)30667-0. doi: 10.1016/j.jpainsymman.2019.11.012. [Epub ahead of print]

PMID:
31765760
2.

Integrative Therapies for Cancer-Related Fatigue.

Arring NM, Barton DL, Brooks T, Zick SM.

Cancer J. 2019 Sep/Oct;25(5):349-356. doi: 10.1097/PPO.0000000000000396.

PMID:
31567463
3.

The Use of Technology to Support Precision Health in Nursing Science.

Starkweather A, Jacelon CS, Bakken S, Barton DL, DeVito Dabbs A, Dorsey SG, Guthrie BJ, Heitkemper MM, Hickey KT, Kelechi TJ, Kim MT, Marquard J, Moore SM, Redeker NS, Schiffman RF, Ward TM, Adams LS, Kehl KA, Miller JL.

J Nurs Scholarsh. 2019 Nov;51(6):614-623. doi: 10.1111/jnu.12518. Epub 2019 Sep 30.

PMID:
31566870
4.

Phase II randomized controlled trial of hypnosis versus progressive muscle relaxation for body image after breast or gynecologic cancer.

Barton DL, Brooks TM, Cieslak A, Elkins GR, Clark PM, Baydoun M, Smith AB, Van Poznak CH.

Breast Cancer Res Treat. 2019 Nov;178(2):357-365. doi: 10.1007/s10549-019-05395-6. Epub 2019 Aug 9.

PMID:
31399932
5.

Impact of using a broad-based multi-institutional approach to build capacity for non-communicable disease research in Thailand.

Potempa K, Rajataramya B, Barton DL, Singha-Dong N, Stephenson R, Smith EML, Davis M, Dinov I, Hampstead BM, Aikens JE, Saslow L, Furspan P, Sarakshetrin A, Pupjain S.

Health Res Policy Syst. 2019 Jun 14;17(1):62. doi: 10.1186/s12961-019-0464-8.

6.

Potential mediators of improvement in painful chemotherapy-induced peripheral neuropathy via a web-based cognitive behavioural intervention.

Knoerl R, Barton DL, Holden JE, Krauss JC, LaVasseur B, Smith EML.

Can Oncol Nurs J. 2018 Jul 1;28(3):178-183. doi: 10.5737/23688076283178183. eCollection 2018 Summer.

7.

Médiateurs potentiels d’amélioration de la neuropathie périphérique chimio-induite douloureuse par une intervention cognitivocomportementale en ligne.

Knoerl R, Barton DL, Holden JE, Krauss JC, LaVasseur B, Smith EML.

Can Oncol Nurs J. 2018 Jul 1;28(3):184-190. doi: 10.5737/23688076283184190. eCollection 2018 Summer. French. No abstract available.

PMID:
31148827
Free PMC Article
8.

Factors influencing the use of extended adjuvant endocrine therapy.

Kadakia KC, Kidwell KM, Barton DL, Schott AF, Hayes DF, Griggs JJ, Henry NL.

Breast Cancer Res Treat. 2019 May;175(1):181-189. doi: 10.1007/s10549-019-05145-8. Epub 2019 Jan 31.

PMID:
30706190
9.

Psychometric properties of the Menopause Specific Quality of Life questionnaire among Thai women with a history of breast cancer.

Phligbua W, Smith EML, Barton DL.

Eur J Oncol Nurs. 2018 Oct;36:75-81. doi: 10.1016/j.ejon.2018.08.008. Epub 2018 Aug 25.

PMID:
30322513
10.

A cancer specific middle-range theory of symptom self-care management: A theory synthesis.

Baydoun M, Barton DL, Arslanian-Engoren C.

J Adv Nurs. 2018 Dec;74(12):2935-2946. doi: 10.1111/jan.13829. Epub 2018 Oct 5. Review.

PMID:
30132962
11.

JABAWS 2.2 distributed web services for Bioinformatics: protein disorder, conservation and RNA secondary structure.

Troshin PV, Procter JB, Sherstnev A, Barton DL, Madeira F, Barton GJ.

Bioinformatics. 2018 Jun 1;34(11):1939-1940. doi: 10.1093/bioinformatics/bty045.

12.

Complementary therapies for fatigue after hematopoietic stem cell transplantation: an integrative review.

Baydoun M, Barton DL.

Bone Marrow Transplant. 2018 May;53(5):556-564. doi: 10.1038/s41409-017-0073-5. Epub 2018 Jan 16.

PMID:
29339799
13.

Acceptance and Use of eHealth/mHealth Applications for Self-Management Among Cancer Survivors.

Jiang Y, West BT, Barton DL, Harris MR.

Stud Health Technol Inform. 2017;245:131-135.

14.

Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy: A Multicenter, Pilot, Randomized, Wait-List Controlled Trial.

Knoerl R, Smith EML, Barton DL, Williams DA, Holden JE, Krauss JC, LaVasseur B.

J Pain. 2018 Apr;19(4):382-394. doi: 10.1016/j.jpain.2017.11.009. Epub 2017 Dec 8.

PMID:
29229430
15.

Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline.

Carter J, Lacchetti C, Andersen BL, Barton DL, Bolte S, Damast S, Diefenbach MA, DuHamel K, Florendo J, Ganz PA, Goldfarb S, Hallmeyer S, Kushner DM, Rowland JH.

J Clin Oncol. 2018 Feb 10;36(5):492-511. doi: 10.1200/JCO.2017.75.8995. Epub 2017 Dec 11.

PMID:
29227723
16.

Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).

Barton DL, Shuster LT, Dockter T, Atherton PJ, Thielen J, Birrell SN, Sood R, Griffin P, Terstriep SA, Mattar B, Lafky JM, Loprinzi CL.

Support Care Cancer. 2018 Apr;26(4):1335-1343. doi: 10.1007/s00520-017-3960-9. Epub 2017 Nov 21.

17.

Heart Failure and Long-Term Survival Among Older Women With Breast Cancer

Harrison JM, Friese CR, Barton DL, Janz NK, Pressler SJ, Davis MA.

Oncol Nurs Forum. 2018 Jan 2;45(1):A1-A11. [Epub ahead of print]

PMID:
29039180
18.

Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).

Barton DL, Sloan JA, Shuster LT, Gill P, Griffin P, Flynn K, Terstriep SA, Rana FN, Dockter T, Atherton PJ, Tsai M, Sturtz K, Lafky JM, Riepl M, Thielen J, Loprinzi CL.

Support Care Cancer. 2018 Feb;26(2):643-650. doi: 10.1007/s00520-017-3878-2. Epub 2017 Sep 18.

19.

Active Vertex Model for cell-resolution description of epithelial tissue mechanics.

Barton DL, Henkes S, Weijer CJ, Sknepnek R.

PLoS Comput Biol. 2017 Jun 30;13(6):e1005569. doi: 10.1371/journal.pcbi.1005569. eCollection 2017 Jun.

20.

Functional status and quality of life among breast cancer survivors with heart failure: results of the Medicare Health Outcomes Survey.

Harrison JM, Davis MA, Barton DL, Janz NK, Pressler SJ, Friese CR.

Support Care Cancer. 2017 Aug;25(8):2463-2473. doi: 10.1007/s00520-017-3653-4. Epub 2017 Mar 8.

PMID:
28275898
21.

Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study.

Barton DL, Schroeder KCF, Banerjee T, Wolf S, Keith TZ, Elkins G.

Menopause. 2017 Jul;24(7):774-782. doi: 10.1097/GME.0000000000000837.

22.

Older Adults at Risk for Atrial Fibrillation Lack Knowledge and Confidence to Seek Treatment for Signs and Symptoms.

McCabe PJ, Barton DL, DeVon HA.

SAGE Open Nurs. 2017 Jan-Dec;3. doi: 10.1177/2377960817720324. Epub 2017 Aug 29.

23.

Feasibility Testing of the Alert for AFib Intervention.

McCabe PJ, Douglas KV, Barton DL, Austin C, Delgado A, DeVon HA.

West J Nurs Res. 2017 Feb;39(2):252-272. doi: 10.1177/0193945916656609. Epub 2016 Jul 11.

24.

Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline.

Rugo HS, Rumble RB, Macrae E, Barton DL, Connolly HK, Dickler MN, Fallowfield L, Fowble B, Ingle JN, Jahanzeb M, Johnston SR, Korde LA, Khatcheressian JL, Mehta RS, Muss HB, Burstein HJ.

J Clin Oncol. 2016 Sep 1;34(25):3069-103. doi: 10.1200/JCO.2016.67.1487. Epub 2016 May 23.

PMID:
27217461
25.

Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes.

Kadakia KC, Loprinzi CL, Atherton PJ, Fee-Schroeder KC, Sood A, Barton DL.

Support Care Cancer. 2016 Mar;24(3):1061-9. doi: 10.1007/s00520-015-2878-3. Epub 2015 Aug 8.

26.

Symptoms: Menopause, Infertility, and Sexual Health.

Barton DL, Ganz PA.

Adv Exp Med Biol. 2015;862:115-41. doi: 10.1007/978-3-319-16366-6_9. Review.

PMID:
26059933
27.

North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.

Park H, Qin R, Smith TJ, Atherton PJ, Barton DL, Sturtz K, Dakhil SR, Anderson DM, Flynn K, Puttabasavaiah S, Le-Lindqwister NA, Padula GD, Loprinzi CL.

Menopause. 2015 Jun;22(6):627-32. doi: 10.1097/GME.0000000000000374.

28.

OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis.

Vincent A, Hoskin TL, Whipple MO, Clauw DJ, Barton DL, Benzo RP, Williams DA.

Arthritis Res Ther. 2014 Oct 16;16(5):463. doi: 10.1186/s13075-014-0463-7.

29.

Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy.

Pachman DR, Weisbrod BL, Seisler DK, Barton DL, Fee-Schroeder KC, Smith TJ, Lachance DH, Liu H, Shelerud RA, Cheville AL, Loprinzi CL.

Support Care Cancer. 2015 Apr;23(4):943-51. doi: 10.1007/s00520-014-2424-8. Epub 2014 Sep 24.

30.

Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).

Barton DL, Thanarajasingam G, Sloan JA, Diekmann B, Fuloria J, Kottschade LA, Lyss AP, Jaslowski AJ, Mazurczak MA, Blair SC, Terstriep S, Loprinzi CL.

Cancer. 2014 Nov 15;120(22):3575-83. doi: 10.1002/cncr.28892. Epub 2014 Jul 9.

31.

Early experience with a brief, multimodal, multidisciplinary treatment program for fibromyalgia.

Vincent A, Whipple MO, Oh TH, Guderian JA, Barton DL, Luedtke CA.

Pain Manag Nurs. 2013 Dec;14(4):228-235. doi: 10.1016/j.pmn.2011.05.001. Epub 2011 Jul 2.

32.

Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.

Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, Loprinzi CL.

J Natl Cancer Inst. 2013 Aug 21;105(16):1230-8. doi: 10.1093/jnci/djt181. Epub 2013 Jul 13.

33.

Sternal skin conductance: a reasonable surrogate for hot flash measurement?

Pachman DR, Loprinzi CL, Novotny PJ, Satele DV, Linquist BM, Wolf S, Barton DL.

Menopause. 2013 Nov;20(11):1164-8. doi: 10.1097/GME.0b013e31828cec53.

34.

Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.

Lavoie Smith EM, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL.

Qual Life Res. 2013 Dec;22(10):2787-99. doi: 10.1007/s11136-013-0379-8. Epub 2013 Mar 30.

35.

Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project.

Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, Barton DL, St Sauver J.

Arthritis Care Res (Hoboken). 2013 May;65(5):786-92. doi: 10.1002/acr.21896.

36.

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.

Barton DL, Burger K, Novotny PJ, Fitch TR, Kohli S, Soori G, Wilwerding MB, Sloan JA, Kottschade LA, Rowland KM Jr, Dakhil SR, Nikcevich DA, Loprinzi CL.

Support Care Cancer. 2013 Apr;21(4):1185-92. doi: 10.1007/s00520-012-1647-9. Epub 2012 Nov 13.

37.

Using one's head to treat menopausal symptoms.

Barton DL, Loprinzi CL.

J Clin Oncol. 2012 Nov 20;30(33):4059-60. doi: 10.1200/JCO.2012.44.9652. Epub 2012 Oct 8. No abstract available.

PMID:
23045579
38.

Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain.

Pachman DR, Barton DL, Swetz KM, Loprinzi CL.

J Clin Oncol. 2012 Oct 20;30(30):3687-96. doi: 10.1200/JCO.2012.41.7238. Epub 2012 Sep 24. Review.

PMID:
23008320
39.

Paced breathing compared with usual breathing for hot flashes.

Sood R, Sood A, Wolf SL, Linquist BM, Liu H, Sloan JA, Satele DV, Loprinzi CL, Barton DL.

Menopause. 2013 Feb;20(2):179-84. doi: 10.1097/gme.0b013e31826934b6.

PMID:
22990758
40.

Hot flashes: the ongoing search for effective interventions.

Kadakia KC, Loprinzi CL, Barton DL.

Menopause. 2012 Jul;19(7):719-21. doi: 10.1097/gme.0b013e3182578d31. No abstract available.

41.

Clinical trials in integrative therapies.

Barton DL, Pachman DR.

Semin Oncol Nurs. 2012 Feb;28(1):10-28. doi: 10.1016/j.soncn.2011.11.003. Review.

PMID:
22281307
42.

Nonestrogenic management of hot flashes.

Loprinzi CL, Barton DL, Qin R.

J Clin Oncol. 2011 Oct 10;29(29):3842-6. doi: 10.1200/JCO.2011.37.5865. Epub 2011 Sep 12. No abstract available.

PMID:
21911722
43.

Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.

Pachman DR, Barton DL, Clayton AC, McGovern RM, Jefferies JA, Novotny PJ, Sloan JA, Loprinzi CL, Gostout BS.

Am J Obstet Gynecol. 2012 Jan;206(1):42.e1-7. doi: 10.1016/j.ajog.2011.06.105. Epub 2011 Jul 13.

44.

A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7.

Pruthi S, Qin R, Terstreip SA, Liu H, Loprinzi CL, Shah TR, Tucker KF, Dakhil SR, Bury MJ, Carolla RL, Steen PD, Vuky J, Barton DL.

Menopause. 2012 Jan;19(1):48-53. doi: 10.1097/gme.0b013e318223b021.

45.

Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).

Kadakia KC, Barton DL, Loprinzi CL, Sloan JA, Otley CC, Diekmann BB, Novotny PJ, Alberts SR, Limburg PJ, Pittelkow MR.

Cancer. 2012 Apr 15;118(8):2128-37. doi: 10.1002/cncr.26374. Epub 2011 Aug 31.

46.

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

Pachman DR, Barton DL, Watson JC, Loprinzi CL.

Clin Pharmacol Ther. 2011 Sep;90(3):377-87. doi: 10.1038/clpt.2011.115. Epub 2011 Aug 3. Review.

PMID:
21814197
47.

The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA.

Wolf SL, Barton DL, Qin R, Wos EJ, Sloan JA, Liu H, Aaronson NK, Satele DV, Mattar BI, Green NB, Loprinzi CL.

Support Care Cancer. 2012 Mar;20(3):625-32. doi: 10.1007/s00520-011-1141-9. Epub 2011 Apr 12.

48.

The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).

Barton DL, Atherton PJ, Bauer BA, Moore DF Jr, Mattar BI, Lavasseur BI, Rowland KM Jr, Zon RT, Lelindqwister NA, Nagargoje GG, Morgenthaler TI, Sloan JA, Loprinzi CL.

J Support Oncol. 2011 Jan-Feb;9(1):24-31. doi: 10.1016/j.suponc.2010.12.008.

49.

Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.

Moraska AR, Atherton PJ, Szydlo DW, Barton DL, Stella PJ, Rowland KM Jr, Schaefer PL, Krook J, Bearden JD, Loprinzi CL.

J Support Oncol. 2010 May-Jun;8(3):128-32.

50.

Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.

Barton DL, LaVasseur BI, Sloan JA, Stawis AN, Flynn KA, Dyar M, Johnson DB, Atherton PJ, Diekmann B, Loprinzi CL.

J Clin Oncol. 2010 Jul 10;28(20):3278-83. doi: 10.1200/JCO.2009.26.6379. Epub 2010 May 24.

Supplemental Content

Loading ...
Support Center